CanSino Biologics
(SEHK) 6185
CanSino Biologics Financials at a Glance
Market Cap
HK$5.50B
Revenue (TTM)
CN¥1.11B
Net Income (TTM)
-CN¥848.43K
EPS (TTM)
-HK$0.01
P/E Ratio
-2228.00
Dividend
HK$0.00
Beta (Volatility)
0.03 (Low)
Dividend
HK$0.00
Beta (Volatility)
0.03 (Low)
Price
HK$23.20
Volume
0
Open
HK$22.64
Price
HK$23.20
Volume
0
Open
HK$22.64
Previous Close
HK$22.28
Daily Range
HK$22.64 - HK$24.08
52-Week Range
HK$19.22 - HK$56.55
Estimated Earnings Date
Aug 21, 2026
Dividend
HK$0.00
Beta (Volatility)
0.03 (Low)
Price
HK$23.20
Volume
0
Open
HK$22.64
Previous Close
HK$22.28
Daily Range
HK$22.64 - HK$24.08
52-Week Range
HK$19.22 - HK$56.55
Estimated Earnings Date
Aug 21, 2026
6185 News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CanSino Biologics
Industry
Biotechnology
Sector
Health CareEmployees
1,134
CEO
Xue Feng Yu, PhD
Website
www.cansinotech.comHeadquarters
Tianjin, 300457, HK
6185 Financials
Key Financial Metrics (TTM)
Gross Margin
98.88%
Operating Margin
-0.16%
Net Income Margin
-0.09%
Return on Equity
-0.02%
Return on Capital
-1.81%
Return on Assets
-0.01%
Earnings Yield
-0.04%
Dividend Yield
0.00%
Payout Ratio
-23.46%
Stock Overview
Market Cap
HK$5.50B
Shares Outstanding
247.04M
Volume
0
Avg. Volume
1.05M
Financials (TTM)
Gross Profit
CN¥826.36M
Operating Income
-CN¥71.07M
EBITDA
-CN¥9.45M
Operating Cash Flow
CN¥71.31M
Capital Expenditure
-CN¥208.82M
Free Cash Flow
-CN¥137.42M
Cash & ST Invst.
CN¥2.07B
Total Debt
CN¥1.16B
CanSino Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥188.56M
+37.5%
Gross Profit
CN¥152.63M
+34.6%
Gross Margin
80.94%
N/A
Market Cap
HK$5.50B
N/A
Market Cap/Employee
HK$4.85M
N/A
Employees
1,134
N/A
Net Income
-CN¥40.06M
-247.0%
EBITDA
-CN¥41.77M
-249.4%
Quarterly Fundamentals
Total Cash
CN¥2.07B
-32.8%
Total Debt
CN¥1.16B
-41.6%
Accounts Receivable
CN¥818.04M
+22.8%
Inventory
CN¥399.75M
+23.9%
Long Term Debt
CN¥949.51M
-15.7%
Short Term Debt
CN¥208.36M
-75.7%
Return on Assets
-0.01%
N/A
Return on Invested Capital
-0.03%
N/A
Free Cash Flow
-CN¥88.54M
-9.1%
Operating Cash Flow
-CN¥57.74M
-318.3%